The Soluble Factor from Oral Cancer Cell Lines Inhibits Interferon-Î³ Production by OK-432 via the CD40/CD40 Ligand Pathway.

Ohe, Go; Kudo, Yasusei; Kamada, Kumiko; Mouri, Yasuhiro; Takamaru, Natsumi; Kudoh, Keiko; Kurio, Naito; Miyamoto, Youji.

Afiliação

Ohe G; Department of Oral Surgery, Tokushima University Graduate School, 3-18-15 Kuramoto-cho, Tokushima 770-8504, Japan.
Kudo Y; Dentistry and Oral Surgery, Takamatsu Municipal Hospital, 847-1 Ko Busshozan-cho, Takamatsu 761-8538, Japan.
Kamada K; Department of Oral Bioscience, Tokushima University Graduate School, 3-18-15 Kuramoto-cho, Tokushima 770-8504, Japan.
Mouri Y; Department of Oral Surgery, Tokushima University Graduate School, 3-18-15 Kuramoto-cho, Tokushima 770-8504, Japan.
Takamaru N; Department of Oral Bioscience, Tokushima University Graduate School, 3-18-15 Kuramoto-cho, Tokushima 770-8504, Japan.
Kudoh K; Department of Oral Surgery, Tokushima University Graduate School, 3-18-15 Kuramoto-cho, Tokushima 770-8504, Japan.
Kurio N; Department of Oral Surgery, Tokushima University Graduate School, 3-18-15 Kuramoto-cho, Tokushima 770-8504, Japan.
Miyamoto Y; Department of Oral Surgery, Tokushima University Graduate School, 3-18-15 Kuramoto-cho, Tokushima 770-8504, Japan.

Cancers (Basel) ; 13(13)2021 Jun 30.

Article em En | MEDLINE | ID: mdl-34209347